Literature DB >> 19723843

Elevations in sex hormones in dogs with sudden acquired retinal degeneration syndrome (SARDS).

Renee T Carter1, Jack W Oliver, Rebecca L Stepien, Ellison Bentley.   

Abstract

Dogs diagnosed with sudden acquired retinal degeneration syndrome (SARDS) commonly are presented with concurrent clinical, physical, and historical findings consistent with hyperadreno-corticism (HAC) at the time of vision loss. Thirteen dogs diagnosed with SARDS on the basis of complete ophthalmic examination and extinguished bright-flash electroretinogram were evaluated for steroid hormonal abnormalities. Signalment, case history, physical examination, and clinicopathological findings were recorded. Serum cortisol and sex-hormone concentrations were measured before and after adrenocorticotropic hormone (ACTH) stimulation. Clinical signs of HAC, systemic hypertension, and proteinuria were commonly found in dogs with SARDS. Elevations in one or more sex hormones were found in 11 (85%) of 13 dogs (95% confidence interval [CI] 65% to 100%); cortisol was elevated in nine (69%) of 13 dogs (95% CI 44% to 94%). A minority of dogs (three [23%] of 13; 95% CI 0.2% to 46%) exhibited only an increase in adrenal sex hormones. Only one dog had completely normal ACTH stimulation test results. Symptoms of HAC were associated with abnormal ACTH stimulation results. Routine ACTH stimulation testing to evaluate cortisol and sex hormones, blood pressure screening, and urinalysis are recommended in these animals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723843     DOI: 10.5326/0450207

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  6 in total

1.  Sudden acquired retinal degeneration syndrome in western Canada: 93 cases.

Authors:  Marina L Leis; Danica Lucyshyn; Bianca S Bauer; Bruce H Grahn; Lynne S Sandmeyer
Journal:  Can Vet J       Date:  2017-11       Impact factor: 1.008

2.  Canine sudden acquired retinal degeneration syndrome: Owner perceptions on the time to vision loss, treatment outcomes, and prognosis for life.

Authors:  Demitrius R Washington; Zhanhai Li; Lani C Fox; Freya M Mowat
Journal:  Vet Ophthalmol       Date:  2020-12-29       Impact factor: 1.644

3.  Optical coherence tomography and molecular analysis of sudden acquired retinal degeneration syndrome (SARDS) eyes suggests the immune-mediated nature of retinal damage.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Helga Kecova; Kabhilan Mohan; Markus H Kuehn
Journal:  Vet Ophthalmol       Date:  2018-08-15       Impact factor: 1.644

4.  Evaluation of the major histocompatibility complex (MHC) class II as a candidate for sudden acquired retinal degeneration syndrome (SARDS) in Dachshunds.

Authors:  Stephanie J Stromberg; Sara M Thomasy; Ariana D Marangakis; Soohyun Kim; Ann E Cooper; Emily A Brown; David J Maggs; Danika L Bannasch
Journal:  Vet Ophthalmol       Date:  2019-02-21       Impact factor: 1.644

5.  Circulating neurohormone imbalances in canine sudden acquired retinal degeneration syndrome and canine pituitary-dependent hypercortisolism.

Authors:  Annie Oh; Melanie L Foster; Katharine F Lunn; Freya M Mowat
Journal:  J Vet Intern Med       Date:  2019-10-29       Impact factor: 3.333

6.  Presumed cancer-associated retinopathy (CAR) mimicking Sudden Acquired Retinal Degeneration Syndrome (SARDS) in canines.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Helga Kecova; Kabhilan Mohan; Grazyna Adamus; Markus H Kuehn
Journal:  Vet Ophthalmol       Date:  2020-12-27       Impact factor: 1.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.